Dr. Chau Yee Ng Invited as Speaker to AMCADS 2025: Sharing Expertise in Vitiligo Treatment and Advanced Dermatologic Surgery 🎤

We are proud to announce that Dr. Chau Yee Ng (MD PhD) was once again invited to serve as a speaker at the prestigious ASIA Master Course in Cosmetic and Dermatologic Surgery (AMCADS 2025) in Malaysia. This forum provides an essential platform for sharing clinical experience and research findings with leading dermatologists and experts across Asia.

Dr. Ng presented on two crucial topics related to vitiligo and procedural dermatology, highlighting the latest techniques and diagnostic approaches developed by the Chang Gung Dermatology team.

Lecture 1: Post-laser Leukoderma: A Clinicopathologic Classification and Imaging-Based Approach to Diagnosis and Management

This presentation focused on the clinical phenomenon and risk assessment of leukoderma (white spots) that may occur following laser treatments. Key discussion points included:

• Risk Evaluation: Discussing the suitability of laser treatment for patients with a predisposition to vitiligo.

• Precision Diagnosis: Demonstrating the application of advanced imaging technologies, such as Optical Coherence Tomography (OCT) and Dermoscopy, for earlier detection of pigment changes.

• Safer Management: Utilizing imaging-based insights to ensure safer and more precise treatment protocols when post-laser leukoderma occurs.

  

  

Lecture 2: Advanced Surgical Techniques in Vitiligo

Drawing upon the team’s extensive experience with nearly 500 cases, this lecture detailed the intricacies of surgical management for stable vitiligo. Dr. Ng elaborated on:

• Comprehensive Experience: Sharing surgical techniques ranging from tissue grafting to cellular suspension transplantation.

• Keys to Success: Emphasizing the critical elements for successful outcomes, including meticulous pre-operative assessment of lesion stability, precise surgical execution, and thorough post-operative care.

Dr. Ng reiterated that every successful case offers the best reward to the patient, and continuous medical advancement is driven by attention to clinical detail and constant international exchange. We look forward to more breakthroughs through such collaborative efforts.